Fellman Ronald L

Fellman Ronald L, Padilla Steven, Liu Avery, Holliman Matthew, Xin Chen, Martin Elizabeth et al.

Clinical OCT revealed valvelike structures in Schlemm canal, correlating with known ex vivo anatomy. This bridges lab findings to living human outflow, enhancing our understanding of glaucoma.

Samuelson Thomas W, De Francesco Ticiana, Ahmed Iqbal Ike K, Gedde Steven J, Paranjpe Vikram R, Singh Kuldev et al.

This case highlights managing severe progressive glaucoma after failed MIGS and medical therapy, where trabeculectomy achieved stability in one eye, emphasizing its role for advanced disease.

Smith Oluwatosin U, Butler Michelle R, Grover Davinder S, Kornmann Helen L, Emanuel Matthew E, Godfrey David G et al.

This study found that GATT safely and significantly reduced eye pressure and medication use for glaucoma after corneal transplant, offering a good alternative to traditional surgeries.

Fellman Ronald L, Grover Davinder S, Smith Oluwatosin U, Kornmann Helen L

Nd:YAG laser shockwave therapy successfully cleared hidden intraluminal blockages in failing XEN-45 stents, immediately reducing IOP. This offers a non-invasive rescue for XEN-45 failures caused by invisible debris.

Cui Qi N, Hays Ron D, Tarver Michelle E, Spaeth George L, Paz Sylvia H, Weidmer Beverly et al.

Researchers developed a new patient-reported survey (Glaucoma Outcomes Survey) to assess health-related quality of life in glaucoma patients considering MIGS. This tool will help understand MIGS's impact on patients' vision-targeted well-being.

Smith Oluwatosin U, Fellman Ronald L, Grover Davinder S, Emanuel Matthew E, Godfrey David G

Moumneh Khaled, Sheybani Arsham, Fellman Ronald L, Godfrey David G, Grover Davinder S

Netarsudil can rarely cause reversible reticular corneal edema, resolving when the medication is stopped. Clinicians should be aware of this potential side effect.

Grover Davinder S, Kornmann Helen L, Fellman Ronald L

Smith Oluwatosin U, Grover Davinder S, Emanuel Mathew E, Godfrey David G, Fellman Ronald L

XEN gel stents safely and effectively lowered eye pressure in three children with congenital glaucoma, offering a viable surgical option for this challenging condition.

Grover Davinder S, Kornmann Helen L, Fellman Ronald L

This review highlights Mitomycin C's historical and evolving role in glaucoma surgery, emphasizing its crucial antifibrotic benefits but also the need for careful application to prevent serious complications.

Fellman Ronald L, Grover Davinder S

This study observed episcleral fluid waves after MIGS, finding outflow is segmented, favors the inferonasal quadrant, and is limited circumferentially. This confirms lab research on glaucoma outflow patterns.

Grover Davinder S, Smith Oluwatosin, Fellman Ronald L, Godfrey David G, Gupta Aditi, Montes de Oca Ildamaris et al.

GATT surgery for open-angle glaucoma showed significant, safe IOP and medication reduction over 24 months, offering a viable long-term treatment option.

Emanuel Matthew E, Grover Davinder S, Fellman Ronald L, Godfrey David G, Smith Oluwatosin, Butler Michelle R et al.

MP-TSCPC effectively lowered IOP and medication use in refractory glaucoma, offering a viable alternative for patients with limited visual potential or high surgical risk, despite some short-term complications.

Grover Davinder S, Fellman Ronald L

This study found a novel ab interno bleb revision technique with a specialized spatula effectively lowered IOP and medication use in failed filtration surgeries, potentially reducing the need for more invasive glaucoma procedures.

Grover Davinder S, Fellman Ronald L

A new dual muscle speculum simplifies Baerveldt implant placement by simultaneously exposing two rectus muscles. This improves surgical efficiency, especially for single surgeons, by easing tube insertion.

Grover Davinder S, Godfrey David G, Smith Oluwatosin, Shi Wei, Feuer William J, Fellman Ronald L

GATT effectively lowered IOP and medication use in eyes with prior incisional glaucoma surgery, offering a safe, successful option for patients failing traditional procedures.

Carreon Teresia, van der Merwe Elizabeth, Fellman Ronald L, Johnstone Murray, Bhattacharya Sanjoy K

This review describes the aqueous outflow pathway as a continuum from the trabecular meshwork to episcleral veins. Understanding this complex, segmental flow is crucial for identifying molecular targets to treat glaucoma's elevated intraocular pressure.

Grover Davinder S, Fellman Ronald L

This study describes a cost-effective method to thermally mark a GATT suture tip, improving visualization during 360-degree trabeculotomy for glaucoma, offering similar safety to microcatheters.

Fellman Ronald L, Feuer William J, Grover Davinder S

Intraoperative episcleral venous fluid wave (EVFW) characteristics correlate with Trabectome outcomes. A diffuse EVFW indicates better outflow, predicting lower post-op IOP, fewer meds, and less need for further surgery.

Grover Davinder S, Smith Oluwatosin, Fellman Ronald L, Godfrey David G, Butler Michelle R, Montes de Oca Ildamaris et al.

Gonioscopy assisted transluminal trabeculotomy (GATT) effectively reduced IOP and medication dependence in primary congenital and juvenile open-angle glaucoma patients, demonstrating promising safety and efficacy comparable to established treatments.

Grover Davinder S, Merritt James, Godfrey David G, Fellman Ronald L

This study found a forniceal conjunctival pedicle flap effectively repaired complex glaucoma drainage device tube erosions long-term, preserving implants and maintaining pressure control, offering a safe solution for these challenging cases.

Godfrey David G, Fellman Ronald L, Neelakantan Arvind

Canal surgeries (Trabectome, Canaloplasty, trabeculotomy) effectively lower intraocular pressure in adult glaucoma patients, offering bleb-free alternatives to traditional surgery with good safety profiles.

Fellman Ronald L, Sullivan E Kenneth, Ratliff Marla, Silver Lewis H, Whitson Jess T, Turner F Darell et al.

Travoprost (both concentrations) lowered IOP more effectively than timolol in glaucoma/OHT patients, offering superior once-daily treatment despite more hyperemia, making it a potent option.